ABSTRACT OBJECTIVES This study sought to evaluate the prognostic significance of left ventricular late gadolinium enhancement (LV-LGE) incidentally found in atrial fibrillation (AF) patients who undergo ablation therapy.
A trial fibrillation (AF) is the most common sustained arrhythmia and can result in heart failure (1), stroke (2), and death (3). To achieve rhythm control, catheter ablation is becoming more common due to improved ablation techniques and limited success with anti-arrhythmic drugs.
In a growing number of centers, preablation cardiac magnetic resonance (CMR) is performed to determine if patients are reasonable candidates for ablation therapy (4) and to provide 3-dimensional (3D) left atrial and pulmonary venous anatomy to help guide catheter navigation (5) . This CMR study also provides left ventricular function and viability information.
Left ventricular late gadolinium enhancement (LV-
LGE) has prognostic value in patients with ischemic and nonischemic cardiomyopathies (6, 7) . Recently, incidental LV-LGE found by CMR in AF patients has been associated with mortality (8) . However, the relationship between incidental LV-LGE in AF patients and specific cardiovascular outcomes has not been well studied. The goal of this study was to determine whether there is an association of incidental LV-LGE with cardiovascular risk factors and cardiovascular disease processes and to study the relationship between LV-LGE and arrhythmia recurrence after ablation. Arrhythmia recurrence curves were determined according to Kaplan-Meier methods, and comparison of recurrence rate was performed using a log-rank test.
METHODS
The Harrell concordance C statistic for arrhythmia recurrence outcomes was used to assess the increase in Table 1 .
LV-LGE. In our AF patient cohort without history of MI, LV-LGE was found in 39 patients (6.5%) with an average LV-LGE extent of 2.1 AE 2.1%. Of these patients, 34 (89.5%) had a normal LV ejection fraction of $55%. The observed pattern of LV-LGE was ischemic in 46% of the patients (subendocardial in Suksaranjit et al. 
DISCUSSION
The purpose of this study was to evaluate the prognostic value of LV-LGE in AF patients who underwent Tables 1 and 2 . Abbreviations as in Tables 1 and 2 . Table 1 . with an ischemic process was detected in 46% of patients with incidentally discovered LV-LGE. The presence of LV-LGE in the remaining patients is presumably due to non-ischemic etiology. Second, the presence of LV-LGE was a significant, independent predictor of arrhythmia recurrence after AF ablation therapy, suggesting that incidental LV-LGE may be an additive risk factor for arrhythmia recurrence.
LV-LGE has been validated against histologic
findings in animal models and in humans where it has been shown to correlate with myocardial fibrosis (13) (14) (15) (16) (17) . Although it is not specific (18), the ischemic
LGE pattern (subendocardial/transmural) usually represents ischemic heart disease (6, 19) . On the other hand, nonischemic LGE representing focal myocardial fibrosis can be found in nonischemic cardiomyopathies (15, 20) and other cardiac conditions (21-23).
In AF populations, the data on incidental LV-LGE patterns and pathophysiology are still limited. In our AF patients without history of MI, LV-LGE was detected in 39 patients (6.5%). In almost one-half of these patients, LV-LGE was seen in an ischemic pattern, which is similar to the findings in the earlier study from Neilan et al. (8) . We further found that atherosclerotic and embolic risk factors were independent predictors of LV-LGE. This could be due to unrecognized coronary artery disease or microembolism in AF patients causing an ischemic LV-LGE pattern. However, the mechanism involved in the development of nonischemic LV-LGE patterns in AF patients is still unclear. This could result from LV remodeling associated with chronic AF (24) or aging (25) , or from another multifactorial, genetic process.
It may also be reflective of the presence of comorbidities and associated myocardial disease.
The prognostic value of LV-LGE has been applied to ischemic and nonischemic cardiomyopathies (6, 7) and aortic stenosis (26) . Recently, unanticipated LV-LGE in AF patients was shown to be an independent predictor of mortality (8) . In our study, we report the prognostic value of incidental LV-LGE for AF ablation outcomes. Patients with LV-LGE had arrhythmia recurrence rates as high as 69% in our cohort. Mechanistically, the presence of fibrosis could render the ventricle less compliant, resulting in impaired relaxation with increased LV filling pressures (27) , leading to increased LA pressures and structural remodeling (SRM) (28) , which is a substrate for AF. The extent of myocardial fibrosis by LGE has been shown to be correlated with severity of diastolic dysfunction (29) . This mechanism is further supported by data from our cohort showing significantly larger LA sizes in patients with LV-LGE.
Similar to earlier studies (30), we also showed LA fibrosis as an independent predictor of AF ablation outcome. Interestingly, there was no significant difference between LA fibrosis, a hallmark of SRM, between patients with and without incidental LV-LGE. Abbreviations as in Tables 1 and 2 . Log rank test p < 0.01 Thus, incidental LV-LGE was an additive predictor of arrhythmia recurrence after ablation.
With superior spatial resolution compared to ultrasound (31, 32) These findings also provide prognostic value in terms of mortality (8) . In situations where CMR is available, it should be considered as the primary imaging modality in arrhythmia patients with no magnetic resonance imaging (MRI) contraindications.
STUDY LIMITATIONS
We do not have data on diastolic LV function to look for association with incidental LV-LGE. However, there are results from a prior study that suggest an association between LV-LGE and diastolic dysfunction (29) . Multiple comparisons are made in our analysis without adjustment methods, and there is a possibility that spurious associations may appear statistically significant because of the number of comparisons being performed. However, LV-LGE is our primary predictor of interest for association with arrhythmia recurrence. We consider LV-LGE the only variable that is a confirmatory finding to the primary hypothesis.
Because this involves only 1 variable, there is no increased false positive issue for LV-LGE being an independent predictor for arrhythmia recurrence. 
